Document 0017
 DOCN  M9460017
 TI    Is the risk of perinatal transmission of human immunodeficiency virus
       increased by the intrapartum use of spiral electrodes or fetal scalp pH
       sampling?
 DT    9404
 AU    Viscarello RR; Copperman AB; DeGennaro NJ; Department of Obstetrics and
       Gynecology, Yale University School; of Medicine, New Haven, Connecticut.
 SO    Am J Obstet Gynecol. 1994 Mar;170(3):740-3. Unique Identifier : AIDSLINE
       MED/94189618
 AB    OBJECTIVE: Our aim was to determine whether the intrapartum use of fetal
       scalp electrodes or fetal scalp pH sampling increases the rate of
       perinatal transmission of human immunodeficiency virus. STUDY DESIGN:
       The rate of perinatal transmission of human immunodeficiency virus in 31
       monitored pregnancies was determined, and those pregnancies were
       compared with a control group of 117 pregnancies. RESULTS: The monitored
       group was comparable to the control group with respect to maternal age,
       race, human immunodeficiency virus risk behavior, CD4+ cell count, p24
       antigen status, and stage of human immunodeficiency virus disease. The
       mean gestational age at delivery and the mean birth weight were similar
       in the monitored group and the control group. The perinatal transmission
       rate for the monitored group (29.0%) was not statistically different
       from that of the control group (25.6%). CONCLUSIONS: If confirmed by
       larger studies, our findings suggest that the intrapartum use of fetal
       scalp electrodes or fetal scalp pH sampling does not appear to increase
       the perinatal transmission of human immunodeficiency virus.
 DE    Adult  Cohort Studies  Electrodes  Female  Fetal Monitoring/*ADVERSE
       EFFECTS  Human  Hydrogen-Ion Concentration  HIV Infections/*TRANSMISSION
       *HIV-1  Pregnancy  Retrospective Studies  Risk Factors  Scalp/PHYSIOLOGY
       Support, Non-U.S. Gov't  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).